论文部分内容阅读
恶性胸腔积液是晚期癌症的常见并发症,严重影响患者生活质量及生存期限,如何有效得控制恶性胸腔积液量是肿瘤研究领域的热点话题,既往多采用单纯化学药物胸腔灌注治疗胸腔积液,疗效欠理想。随着生物制剂在临床的广泛应用,癌性胸腔积液的控制率得以提高。我院自2003年5月至2006?
Malignant pleural effusion is a common complication of advanced cancer, seriously affecting the quality of life and life expectancy of patients, how to effectively control the volume of malignant pleural effusion is a hot topic in the field of cancer research, the past, the use of chemo-pleural chemotherapy alone pleural effusion , Efficacy less than ideal. With the wide application of biological agents in clinical practice, the control rate of cancerous pleural effusion is improved. Our hospital from May 2003 to 2006?